The Global Prevalence of Helicobacter Pylori: A Systematic Review and Meta-Analysis of Population-Based Studies from 1970 to 2016

Wee Khoon Ng,James Hooi,Lily Lai,Michael Suen,Fox E. Underwood,Divine Tanyingoh,David Y. Graham,Justin C. Wu,Vincent Wong,Francis K. Chan,Joseph J. Sung,Gilaad Kaplan,Siew C. Ng
DOI: https://doi.org/10.1016/s0016-5085(17)30919-8
IF: 29.4
2017-01-01
Gastroenterology
Abstract:Background: In the past few decades, the epidemiology of Helicobacter pylori (HP) has evolved.However, recent data reporting the global prevalence of HP are lacking.This systematic review and meta-analysis provides the most updated global prevalence of HP in the 21 st century.Methods: We performed a systematic search of data on HP prevalence published from 1 Jan 1970 till 1 Jan 2016 using Medline (R) and Embase.We included population-based studies reporting HP prevalence.We analyzed data using the United Nation (UN) geoscheme regions and individual countries.We used a random effects model to calculate pooled prevalence estimates with 95% confidence intervals (CI) weighted by study size.We extrapolated prevalence estimates to UN population sizes in 2015 to obtain the estimated number of individuals affected with HP.Results: Among 14006 reports screened, 263 full text articles on the prevalence of HP were identified and 184 were included in the final analysis covering 63 countries.From the available data collected, UN regions with the highest pooled HP prevalence were Africa (79.1%, 95% CI 62.6-77.7),and Latin America and the Caribbean (63.4%, 59.2-67.6),whilst Oceania (24.4%, 18.5-30.4)and Northern America (37.1%, 32.3-41.9)had the lowest prevalence (Table 1, Figure 1).For individual countries, HP prevalence ranged from as low as 18.9% (95% CI 13.1-24.7) in Switzerland, 22.1% (17.8-26.5) in Denmark, to 87.7% (83.1-92.2) in Nigeria and 86.4% (84.9-87.9) in Portugal.Based on the HP prevalence estimates of each UN region, we estimated that there were approximately 4.4 billion HP positive individuals globally in 2015.Conclusion: This first global assessment of population-based prevalence of HP demonstrates that more than half of the world's population remains infected, with wide variation between countries.Global efforts for HP eradication may use these data to focus on the areas with higher prevalence.Table 1: HP prevalence and number of people living with HP in the general population divided by regions 'n' refers to the number of reporting studies
What problem does this paper attempt to address?